Association between BMI and metabolic syndrome and adenomatous colonic polyps in Korean men

Obesity

Volumn 16, Issue 6, 2008, Pages 1434-1439

  Lee, Go Eun ^a   Park, Hye S ^b   Yun, Kyung E ^b   Jun, Sung H ^a   Kim, Hong K ^a   Cho, Sung Il ^c   Kim, Jin H ^a,b  

^a Asan Medical Center   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

^c Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

TRIACYLGLYCEROL;

ADENOMATOUS POLYP; ARTICLE; BLOOD; BODY MASS; COLON POLYP; ETHNOLOGY; HEALTH SURVEY; HUMAN; INCIDENCE; KOREA; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PATHOPHYSIOLOGY; RISK FACTOR; STATISTICAL MODEL;

ADENOMATOUS POLYPS; BODY MASS INDEX; COLONIC POLYPS; HEALTH SURVEYS; HUMANS; INCIDENCE; KOREA; LOGISTIC MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; RISK FACTORS; TRIGLYCERIDES;

EID: 44449142527     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2008.216     Document Type: Article

References (40)

1. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003;348:1625-1638.
2. Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 2004;4:579-591.
3. Cowey S, Hardy RW. The metabolic syndrome: a high-risk state for cancer? Am J Pathol 2006;169:1505-1522.
4. Colangelo LA, Gapstur SM, Gann PH, Dyer AR, Liu K. Colorectal cancer mortality and factors related to the insulin resistance syndrome. Cancer Epidemiol Biomarkers Prev 2002;11:385-391.
5. Goodwin PJ, Ennis M, Pritchard KI et al. Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study. J Clin Oncol 2002;20:42-51.
6. Hsing AW, Chua S Jr, Gao YT et al. Prostate cancer risk and serum levels of insulin and leptin: a population-based study. J Natl Cancer Inst 2001;93:783-789.
7. Saito K, Inoue S, Saito T et al. Augmentation effect of postprandial hyperinsulinaemia on growth of human hepatocellular carcinoma. Gut 2002;51:100-104.
8. Furberg AS, Thune I. Metabolic abnormalities (hypertension, hyperglycemia and overweight), lifestyle (high energy intake and physical inactivity) and endometrial cancer risk in a Norwegian cohort. Int J Cancer 2003;104:669-676.
9. International Obesity Task Force. The Asia-Pacific regional obesity guidelines, Sydney: International Obesity Task Force, 1999.
10. Korean Ministy of Health and Welfare. The Korean National Health Nutrition Examination Survey 1998, 1999.
11. Korean Ministy of Health and Welfare. The Korean National Health Nutrition Examination Survey 2005, 2006.
12. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-2497.
13. Park HS, Oh SW, Cho SI, Choi WH, Kim YS. The metabolic syndrome and associated lifestyle factors among South Korean adults. Int J Epidemiol 2004;33:328-336.
14. Korea National Statistics Office. 2005 Statistics of cause of death. 2006.
15. Frezza EE, Wachtel MS, Chiriva-Internati M. Influence of obesity on the risk of developing colon cancer. Gut 2006;55:285-291.
16. Muto T, Nagawa H, Watanabe T, Masaki T, Sawada T. Colorectal carcinogenesis: histological review. Dis Colon Rectum 1997;40(Suppl 10):S80-S85.
17. Grundy SM, Cleeman JI, Daniels SR et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005;112:2735-2752.
18. Alberti kg, Zimmet P, Shaw J. IDF Epidemiology Task Force Consensus Group. The metabolic syndrome - a new worldwide definition. Lancet 2005;366:1059-1062.
19. Lee SY, Park HS, Kim DJ et al. Appropriate waist circumference cutoff points for central obesity in Korean adults. Diabetes Res Clin Pract 2007;75:72-80.
20. Gunter MJ, Leitzmann MF. Obesity and colorectal cancer: epidemiology, mechanisms and candidate genes. J Nutr Biochem 2006;17:145-156.
21. McMillan DC, Sattar N, McArdle CS. ABC of obesity. Obesity and cancer. BMJ 2006;333:1109-1111.
22. Wang YY, Lin SY, Lai WA, Liu PH, Sheu WH. Association between adenomas of rectosigmoid colon and metabolic syndrome features in a Chinese population. J Gastroenterol Hepatol 2005;20:1410-1415.
23. Kono S, Handa K, Hayabuchi H et al. Obesity, weight gain and risk of colon adenomas in Japanese men. Jpn J Cancer Res 1999;90:805-811.
24. Somasundar P, McFadden DW, Hileman SM, Vona-Davis L. Leptin is a growth factor in cancer. J Surg Res 2004;116:337-349.
25. Garofalo C. Surmacz E. Leptin and cancer. J Cell Physiol 2006;207:12-22.
26. Stattin P, Lukanova A, Biessy C et al. Obesity and colon cancer: does leptin provide a link? Int J Cancer 2004;109:149-152.
27. Stattin P, Palmqvist R, Soderberg S et al. Plasma leptin and colorectal cancer risk: a prospective study in Northern Sweden. Oncol Rep 2003;10:2015-2021.
28. Bloomgarden ZT. Third Annual World Congress on the Insulin Resistance Syndrome: associated conditions. Diabetes Care 2006;29:2165-2174.
29. Giovannucci E. Insulin, insulin-like growth factors and colon cancer: a review of the evidence. J Nutr 2001;131(Suppl 11):S3109-S3120.
30. Singh P, Rubin N. Insulinlike growth factors and binding proteins in colon cancer. Gastroenterology 1993;105:1218-1237.
31. Colangelo LA, Gapstur SM, Gann PH, Dyer AR, Liu K. Colorectal cancer mortality and factors related to the insulin resistance syndrome. Cancer Epidemiol Biomarkers Prev 2002;11:385-391.
32. Powell DR, Suwanichkul A, Cubbage ML et al. Insulin inhibits transcription of the human gene for insulin-like growth factor-binding protein-1. J Biol Chem 1991;266:18868-18876.
33. LeRoith D, Baserga R, Helman L, Roberts CT Jr. Insulin-like growth factors and cancer. Ann Intern Med 1995;122:54-59.
34. Hu FB, Manson JE, Liu S et al. Prospective study of adult onset diabetes mellitus (type 2) and risk of colorectal cancer in women. J Natl Cancer Inst 1999;91:542-547.
35. Larsson SC, Giovannucci E, Wolk A. Diabetes and colorectal cancer incidence in the cohort of Swedish men. Diabetes Care 2005;28:1805-1807.
36. Jee SH, Ohrr H, Sull JW et al. Fasting serum glucose level and cancer risk in Korean men and women. JAMA 2005;293:194-202.
37. Bird CL, Ingles SA, Frankl HD et al. Serum lipids and adenomas of the left colon and rectum. Cancer Epidemiol Biomarkers Prev 1996;5:607-612.
38. Akerlund JE, Bjorkhem I, Angelin B, Liljeqvist L, Einarsson K. Apparent selective bile acid malabsorption as a consequence of ileal exclusion: effects on bile acid, cholesterol, and lipoprotein metabolism. Gut 1994;35:1116-1120.
39. Anan F, Takahashi N, Shinohara T et al. Smoking is associated with insulin resistance and cardiovascular autonomic dysfunction in type 2 diabetic patients. Eur J Clin Invest 2006;36:459-465.
40. Yoshida I, Suzuki A, Vallée M et al. Serum insulin levels and the prevalence of adenomatous and hyperplastic polyps in the proximal colon. Clin Gastroenterol Hepatol 2006;4:1225-1231.